Drugs / Methalazine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06667934 Comparator | Oct 2024 → May 2025 overdue | ulcerative colitis | The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Methalazine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06667934 ↗ |
| Route | Rectal | “Methalazine suppository was given rectally once a day” NCT06667934 ↗ |